Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|6|605-624

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.6, 2012-03, pp. : 605-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights on the Xenobiotic-Sensing Nuclear Receptors in Liver Diseases- CAR and PXR-

By  

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 614-621

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Non-Steroidal FXR Antagonists Development for Therapeutic Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2175-2187

Bentham Science Publishers

Access to resources Recommend Favorite

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

By Oberman Lindsay M  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1819-1825

Informa Healthcare

Access to resources Recommend Favorite

Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1426-1429

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond CAR and PXR

By  

Current Drug Metabolism, Vol. 6, Iss. 4, 2005-08 ,pp. : 385-397

Bentham Science Publishers

Access to resources Recommend Favorite